Pharmacy Daily | Spiriva compliance program

BOEHRINGER Ingelheim has revamped its Spiriva Compliance Program, with the made-over two session program now attracting $25 per patient of professional services revenue. The program, to be delivered through the GuildCare suite, will be launched this month, and for consistency the currently available Spiriva New to Therapy Program will also now offer a total of $25 remuneration over two sessions. The freshly designed program aims to help ensure COPD patients are taking their Spiriva medication “daily and long term”. Guild President Kos Sclavos urged pharmacies to boost their professional services offering by taking part in the program, because “by working alongside GuildCare and supportive companies such as Boehringer Ingelheim it shows the Government collaboration which is encouraged under the National Strategy for Quality US of Medicines”. For more information contact GuildCare on 1300 647 492.

---

The above article was sent to subscribers in Pharmacy Daily's issue from 15 Aug 11
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 15 Aug 11